Form 4: Director Sells CYPH Shares in Trust Liquidation

Christopher Mirabelli, a director of Cypherpunk Technologies Inc., sold 676,319 shares of common stock at $3.14 per share as part of liquidating distributions from two investment entities.

Summary

• Christopher Mirabelli, a director of Cypherpunk Technologies Inc., reported the sale of 676,319 shares of the company's common stock.
• The sales occurred on November 17, 2025, at a weighted average price of $3.14 per share, with transaction prices ranging from $2.40 to $3.40.
• The shares were sold as part of liquidating distributions from HCV VIII Liquidating Trust (261,840 shares) and HealthCare Ventures IX, L.P. (414,479 shares).
• These transactions were made pursuant to a Rule 10b5-1(c) plan.
• Following these transactions, Mirabelli's beneficial ownership includes 20,914 shares held directly and 418,752 shares held indirectly (416,616 via HCV Liquidating Trust and 2,136 via Nine Capital Partners).

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a large insider sale can be perceived negatively, the explicit reason (liquidation of investment vehicles) and the existence of a 10b5-1 plan mitigate the negative interpretation, suggesting it's not a reflection of the director's immediate view on the company's prospects.

Positives

• The sales were part of a pre-arranged Rule 10b5-1(c) plan, indicating a structured, non-discretionary transaction rather than an immediate reaction to company news.
• The sales are attributed to the wind-up and liquidation of investment entities, not necessarily a negative view on the company's future prospects by the director.

Negatives

• A significant number of shares (676,319) were sold by a director, which can sometimes be interpreted negatively by the market.
• The sales occurred at a weighted average price of $3.14, which is within a range that includes prices as low as $2.40.

Risks

• The market might interpret a large insider sale as a lack of confidence, potentially leading to downward pressure on the stock price.
• The liquidation of investment trusts that held a significant stake could introduce additional selling pressure if remaining shares are also distributed or sold.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing primarily details an insider transaction related to the liquidation of specific investment vehicles, rather than reflecting broader industry trends or competitive positioning for Cypherpunk Technologies Inc.

Related Party Transactions

• The sales were conducted by HCV VIII Liquidating Trust and HealthCare Ventures IX, L.P., entities in which the reporting person, Christopher Mirabelli, has an indirect beneficial interest and disclaims ownership except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders may perceive the large sale by a director, even if for liquidation purposes, as a potential signal, which could lead to short-term price volatility.
• The liquidation of significant institutional holders could reduce institutional ownership and potentially liquidity in the stock.

Key Dates

Recommendation

While a large insider sale typically warrants caution, the context of this transaction as a pre-planned liquidation from investment vehicles, rather than a discretionary sale based on new information, suggests it may not reflect a change in the director's view on the company's fundamentals. Investors should hold and monitor future company performance and other insider activity, as this specific event is tied to external entity wind-ups.

Keywords

Cypherpunk Technologies, CYPH, Christopher Mirabelli, Insider Sale, Form 4, Stock Transaction, Director, Liquidation, HCV VIII Liquidating Trust, HealthCare Ventures IX